Foldink logo — Biotechnology company that is creating bioinks for 3D biopri...

Foldink

Biotechnology company that is creating bioinks for 3D bioprinting, an advanced method for tissue engineering.

Founded 2018 United States Frisco, United States 16 employees Biotechnology, Life Sciences

General Information

Company Name Foldink
Founded Year 2018
Location United States Frisco, United States +1
Founders / Decision Makers
Team member
Employees 16
Industries Biotechnology, Life Sciences
Social

Get notified when Foldink moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Foldink

Foldink is a biotechnology startup focused on revolutionizing the field of tissue engineering and regenerative medicine through 3D bioprinting technology. The company's bioinks and 3D bioprinters enable biomedical scientists to develop living tissue constructs, with applications ranging from scientific experiments to the development of pharmaceutical and cosmetic products. Foldink's ultimate goal is to facilitate the clinical application of 3D printed organs and tissues as a viable alternative to traditional organ transplantation, thus addressing the critical shortage of donor organs. By making 3D bioprinting technology accessible to laboratories worldwide, Foldink aims to accelerate the advancement of tissue engineering and regenerative medicine. Founded in 2018 and headquartered in the United States, Foldink is at the forefront of driving the practical implementation of 3D bioprinting in healthcare. The company's commitment to overcoming the existing limitations in the accessibility of this technology positions it as a significant player in the field. As the promising potential of bioprinted organs continues to emerge, Foldink's innovative approach and advanced solutions make it a compelling investment opportunity for venture capitalists seeking to support groundbreaking ventures in biotechnology.

Taxonomy: 3D Bioprinting, Tissue Engineering, Regenerative Medicine, Bioinks, Biomedical Research, Living Tissue Constructs, Pharmacological Research, Cosmetics, Pharmaceutical Products, Organ Transplantation, Microextrusion Syringe-Based System, Cell-laden Tissue Scaffolds, Clinical Application, Laboratory Equipment

No funding data available for Foldink yet.

Get notified when Foldink raises funding

Foldink Alternatives & Competitors

Foldink vs
XenoTherapeutics
XenoTherapeutics United States

Advancing Xenotransplantation to Therapeutic Reality

9 employees
Biotechnology
Foldink vs

Pioneering Regenerative Medicine

69 employees
Foldink vs

Helping Science, Innovating Health

8 employees
Biotechnology

FAQ About Foldink

Biotechnology company that is creating bioinks for 3D bioprinting, an advanced method for tissue engineering.
Foldink was founded in 2018.
Foldink is headquartered in Frisco, United States.
Foldink operates in the following industries: Biotechnology, Life Sciences.
Foldink has approximately 16 employees.
Top alternatives and competitors to Foldink include XenoTherapeutics, CollPlant, BIOFABICS - 3D Biotissue Analogues, Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA, Humacyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Foldink and XenoTherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Foldink and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy